Skip to content

Telemonitoring of congestive heart failure patients through a personal health system - technological feasibility study

Telemonitoring of congestive heart failure patients through a personal health system - technological feasibility study - Technological feasibility of telemonitoring in heart failure patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31880
Enrollment
25
Registered
2008-09-22
Start date
2008-06-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

monitoring heart failure

Interventions

None listed

Sponsors

Intel Corporation
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with congestive heart failure in a stable condition wether or not post-surgery, treated by a cardiologist. Patients must be capable of handling the computer and the monitoring equipment Patients must understand the instructions by nurse and doctor

Exclusion criteria

Exclusion criteria: Progressive heart failure. No ADSL or insufficient knowledge of English ( according to a simple language test) Serious co-morbidity and end-stage disease of any kind Mental shortcomings

Design outcomes

Primary

MeasureTime frame
1. What was the patient*s satisfaction rating ( incl. confidence in PHS ) of their PHS experience ? 2. What was the nurse*s satisfaction rating of their PHS experience ? 3. What was the GP/Specialist*s satisfaction rating of their PHS experience ? 4. What was the average time spent per service center nurse per month ? 5. What percentage of the equipment malfunctioned ? 6. What was the patient*s adherence rate to the PHS ( incl number of patients refusing to participate ) ? 7. What was the average length of time from monitoring to nurse call-back ?

Secondary

MeasureTime frame
1 Blood Pressure Control. Evaluation of the change and variation of daily BP measurements taken over a 3/6 month period of time. 2. Weight Control. Evaluation of the change and variation of daily weight measurements taken over a 3 month period of time. 3. Blood Oxygen Saturation Control. Evaluation of the change and variation of daily blood oxygen saturation measurements taken over a 3 month period of time. 4. Qualitative data (observations, anecdotes, patient comments, etc.) on the installation, training, patient/caregiver/clinician/technician experience, etc.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)